Alphamab Oncology (stock code: 9966.HK) today announced that the first patient has been dosed in a phase III clinical study (JSKN016-301) evaluating JSKN016, a novel TROP2/HER3 bispecific ...

Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company focused on rare diseases, announced that a comprehensive summary of clinical trials evaluating HyBryte(TM) (synthetic hypericin) for ...

Findings from two early clinical studies suggest a new dual-action antimalarial drug candidate is well tolerated in humans. The first-in-class clinical candidate, MK7602, is being developed by WEHI ...

START will leverage Trialing’s platform to distribute curated information on ongoing early-phase oncology trials.

Artelo Biosciences (NASDAQ:ARTL) is expanding its development pipeline into ophthalmology with a new clinical study evaluating its drug candidate ART27.13 for the treatment of glaucoma. The San ...

Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced that its external research ...

The Clinical Trials Office at Saint Louis University supports innovative clinical investigative research at the SLU School of Medicine. Our office provides clinical trial management for ...

It’s a well-known fact for anyone who has ever tried navigating the world of cancer clinical trials: Finding a research trial that’s a match for you isn’t easy. “It’s a kind of Wild West out there,” ...

Our Care Advisors will connect you with the best healthcare provider for your needs. MSK is a leader in cancer clinical trials. We often have many trials at a time, researching different types of ...

Arango today announced that PSI CRO, a global clinical research organization, has reduced clinical trial site identification from up to six weeks to minutes using SYNETIC™, an AI-enabled knowledge ...

The demand for clarity from National Institutes of Health Director Dr. Jayanta “Jay” Bhattacharya comes on the heels of a ...